Micotef (Miconazole)

Miconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesizing ergosterol, a key component of fungal cell membranes. By blocking this pathway, the drug disrupts membrane integrity, leading to inhibited growth and death of Candida organisms that cause oral and throat infections.

The dosage of Micotef is determined by the prescribing healthcare professional based on the severity of the infection, patient age, and clinical judgment. Patients should follow the prescriber's instructions and the product label, and should not alter the dose without medical advice.

Safety of Micotef in pregnancy or while breastfeeding has not been definitively established. It should be used only if the potential benefit outweighs any possible risk to the fetus or infant, and this decision should be made in consultation with a qualified healthcare provider.

To request Micotef, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Micotef’s active ingredient, miconazole, belongs to the imidazole class and offers broad activity against Candida species. Compared with polyene antifungals like nystatin, miconazole often provides a more convenient dosing schedule and may have a lower incidence of taste disturbances, though individual response varies.

Micotef should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposing it to direct sunlight.

Micotef is applied directly to the affected oral or throat area using the provided dosage form. The patient should follow the prescriber's instructions regarding the frequency and duration of application, ensuring the medication contacts the mucosal surfaces for optimal effect.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and significant hepatic dysfunction. Patients should seek immediate medical attention if they experience symptoms like widespread rash, swelling, difficulty breathing, or persistent liver-related complaints.

Micotef should not be used by individuals with a known hypersensitivity to miconazole or other imidazole antifungals. Caution is also advised for patients with severe liver disease, and it should be avoided in pregnant or breastfeeding women unless clearly indicated by a healthcare professional.